Tulieve®
(tulathromycin injection) Injectable Solution
Tulieve® (tulathromycin injection) Injectable Solution is the affordable alternative to Draxxin® (tulathromycin injection) Injectable Solution, delivering the same single shot, rapidly absorbed, long acting, broad-spectrum activity against an equally wide range of diseases, and thanks to our exclusive plastic bottles, less risk of product loss.
Target Species: Beef cattle, Non-Lactating dairy cattle (including dairy calves), Veal calves, Swine
Product Attributes
-
Ready-to-use semi-synthetic marcolide antibiotic
-
Low-volume dose
-
Single shot, rapidly absorbed and long acting
-
Highly effective, broad-spectrum antibiotic
-
Plastic bottles reduce risk of product loss
-
Short meat withdrawal times - 18 days beef, 5 days swine
-
Available in 1 liter and 500 mL plastic hanger bottles
-
Also available in 250 mL and 100 mL plastic bottles
-
FDA approved
CAUTION: Federal (USA) law restricts this drug use by or on the order of a licensed veterinarian.
IMPORTANT SAFETY INFORMATION FOR CATTLE: Do not use in female dairy cattle 20 months of age or older, including dry dairy cows. Effects on reproductive performance, pregnancy, and lactation have not been determined. Tulieve® has a pre-slaughter withdrawal time of 18 days. Tulieve® should not be used in animals known to be hypersensitive to the product.
IMPORTANT SAFETY INFORMATION FOR SWINE: Tulieve® has a pre-slaughter withdrawal time of 5 days. Tulieve® should not be used in animals known to be hypersensitive to the product.
-
Active Ingredient(s)
100 mg of tulathromycin per mL
-
Dosage Form
Ready-to-use sterile solution for injection
-
Indications
Beef and Non-lactating Dairy Cattle
BRD-Tulieve® Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.
IBK-Tulieve® Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.
Foot Rot-Tulieve® Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Suckling Calves, Dairy Calves, and Veal Calves
BRD-Tulieve® Injectable Solution is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.
Swine
Tulieve® Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.
-
Dosage and Administration
Cattle
Inject subcutaneously as a single dose in the neck at a dosage of 2.5 mg/kg (1.1 mL/100 lb) bodyweight (BW). Do not inject more than 10 mL per injection site.
Table 1. Tulieve® Cattle Dosing Guide
Swine
Inject intramuscularly as a single dose in the neck at a dosage of 2.5 mg/kg (0.25 mL/22lb) BW. Do not inject more than 2.5 mL per injection site.
Table 2. Tulieve® Swine Dosing Guide
-
Storage
Store at 59° to 86°F (15° to 30°C). Exposure to temperature up to 104°F (40°C) may be tolerated provided the mean kinetic temperature does not exceed 77°F (25°C); however, such exposure should be minimized. Exposure to temperature down to 36°F (2°C) may be tolerated. For 50 & 100 mL vials: Use within 60 days of the first puncture and puncture a maximum of 52 times. For 250, 500 & 1000 mL vials: Use within 60 days of the first puncture and puncture a maximum of 80 times. If using a needle or draw-off spike larger than 16 gauge discard any remaining product immediately after use.
A Comprehensive Antibiotic Portfolio
Norbrook® now covers five classes of antibiotics.
© 2023 Norbrook Laboratories Limited. The Norbrook logos and Tulieve are registered trademarks of Norbrook Laboratories Limited. Draxxin is a trademark of ZOETIS SERVICES LLC. All rights reserved.
Prefer to speak directly to a member of our team?
Norbrook®, Inc.
We are open Mon - Fri 8:00am - 5:00pm CST
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.
